Ciloa Secures €5 Million for the Development of Its New Generation of Biomedicines and Vaccines Using Exosomes
The company finalized a €3.5 million fundraising and obtained €1.5 million in public funding as part of the "Emerging Infectious Diseases and CBRN Threats" call for proposals of the France 2030
Source: finanznachrichten.de